1. Home
  2. KRYS

as 06-18-2024 9:30am EST

$
-
-
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Stocks

Health Care

Biotechnology: Biological Products (No Diagnostic Substances)

Nasdaq

Krystal Biotech Inc is engaged in the healthcare sector in the United States. It is focused on the development of easy-to-use, redosable gene therapies to improve the lives of patients living with debilitating diseases. The company used its proprietary gene therapy platform, STAR-D to develop treatments for rare or orphan dermatological indications caused by the absence of or a mutation in a single gene. It plans to leverage its platform to expand its pipeline to include other dermatological indications in the future. The company has one operating segment, which is the business of developing and commercializing pharmaceutical products.

Founded: 2015 Country:
United States
United States
Employees: 229 City: PITTSBURGH
Market Cap: 4.9B IPO Year: 2017
Target Price: $175.67 AVG Volume (30 days): 296.5K
Analyst Decision: Strong Buy Number of Analysts: 9
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: 1.88 EPS Growth: N/A
52 Week Low/High: $93.95 - $191.78 Next Earning Date: 08-05-2024
Revenue: $95,949,000 Revenue Growth: N/A
Revenue Growth (this year): 431.86% Revenue Growth (next year): 61.87%

KRYS Daily Stock ML Predictions

Stock Insider Trading Activity of Krystal Biotech Inc. (KRYS)

Name Ticker Relationship Date Transaction Cost Per Share Shares Total Value Securities Owned After Transaction(s) SEC Form 4
Krishnan Krish S KRYS President and CEO Jun 11 '24 Sell $178.14 1,871 $333,308.73 1,525,882 SEC Form 4
Krishnan Krish S KRYS President and CEO Jun 11 '24 Sell $177.38 6,358 $1,127,772.50 1,527,753 SEC Form 4
Krishnan Krish S KRYS President and CEO Jun 11 '24 Sell $176.38 5,867 $1,034,792.13 1,534,111 SEC Form 4
Krishnan Krish S KRYS President and CEO Jun 11 '24 Sell $175.33 4,975 $872,273.22 1,539,978 SEC Form 4
Krishnan Krish S KRYS President and CEO Jun 11 '24 Sell $174.50 1,724 $300,831.45 1,544,953 SEC Form 4
Krishnan Krish S KRYS President and CEO Jun 11 '24 Sell $173.41 1,206 $209,137.28 1,546,677 SEC Form 4
Krishnan Krish S KRYS President and CEO Jun 11 '24 Sell $172.24 2,099 $361,528.61 1,547,883 SEC Form 4
Krishnan Krish S KRYS President and CEO Jun 11 '24 Sell $171.40 900 $154,256.58 1,549,982 SEC Form 4
Krishnan Krish S KRYS President and CEO Jun 11 '24 Sell $178.36 998 $177,999.69 1,587,262 SEC Form 4
Krishnan Krish S KRYS President and CEO Jun 11 '24 Sell $177.68 5,447 $967,814.24 1,588,260 SEC Form 4
Krishnan Krish S KRYS President and CEO Jun 11 '24 Sell $176.68 5,705 $1,007,951.41 1,593,707 SEC Form 4
Krishnan Krish S KRYS President and CEO Jun 11 '24 Sell $175.76 4,550 $799,693.44 1,599,412 SEC Form 4
Krishnan Krish S KRYS President and CEO Jun 11 '24 Sell $174.83 4,000 $699,304.40 1,603,962 SEC Form 4
Krishnan Krish S KRYS President and CEO Jun 11 '24 Sell $173.49 1,318 $228,656.53 1,607,962 SEC Form 4
Krishnan Krish S KRYS President and CEO Jun 11 '24 Sell $172.21 1,882 $324,104.49 1,609,280 SEC Form 4
Krishnan Krish S KRYS President and CEO Jun 11 '24 Sell $171.49 1,100 $188,636.80 1,611,162 SEC Form 4
Krishnan Suma KRYS President, R&D Jun 11 '24 Sell $178.36 998 $177,999.69 1,587,262 SEC Form 4
Krishnan Suma KRYS President, R&D Jun 11 '24 Sell $177.68 5,447 $967,814.24 1,588,260 SEC Form 4
Krishnan Suma KRYS President, R&D Jun 11 '24 Sell $176.68 5,705 $1,007,951.41 1,593,707 SEC Form 4
Krishnan Suma KRYS President, R&D Jun 11 '24 Sell $175.76 4,550 $799,693.44 1,599,412 SEC Form 4
Krishnan Suma KRYS President, R&D Jun 11 '24 Sell $174.83 4,000 $699,304.40 1,603,962 SEC Form 4
Krishnan Suma KRYS President, R&D Jun 11 '24 Sell $173.49 1,318 $228,656.53 1,607,962 SEC Form 4
Krishnan Suma KRYS President, R&D Jun 11 '24 Sell $172.21 1,882 $324,104.49 1,609,280 SEC Form 4
Krishnan Suma KRYS President, R&D Jun 11 '24 Sell $171.49 1,100 $188,636.80 1,611,162 SEC Form 4
Krishnan Suma KRYS President, R&D Jun 11 '24 Sell $178.14 1,871 $333,308.73 1,525,882 SEC Form 4

Share on Social Networks: